Facility Trends: Modularization and Single Use - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Facility Trends: Modularization and Single Use
Pharmaceutical Technology spoke with INTERPHEX 2013 conference-session presenters to gain insight on trends in facility and process design.


Pharmaceutical Technology
Volume 37, Issue 5, pp. 76-78

The conference schedule at INTERPHEX 2013 covered a wide range of topics, including facility and process design. Pharmaceutical Technology interviewed Craig Sandstrom, director of process engineering at Fluor; Par Almhem, president of ModWave and Modular Partners; and Jeff Odum, director of operations at IPS–Integrated Project Services, to gain their perspectives on trends in facility and process design.

Modularization

Modularization has been used by other industries for decades and, over the past few years, has been more accepted by the bio/pharmaceutical industry. Modularization is fast becoming an essential component of bio/pharmaceutical facility design. Use of modularization is growing because it meets the industry needs for reduced cost, accelerated construction schedules, and quality construction.

PharmTech: What are some of the considerations for using modularization?

Sandstrom (Fluor): Typically people have certain cost, schedule, and quality goals for their projects. Early on in a project, an effort is undertaken to look at the site and region where the facility will be constructed and also the facility design itself to determine what opportunities exist to address these cost, schedule, and quality issues.

Some of the local or regional issues include labor availability, labor rates, and associated logistics, such as what the site has in terms of being able to get people and materials to the site. Limitations in this area may drive a desire to try to move some of those activities offsite.

In addition, there is a desire to accelerate schedules. People want to make decisions and capital commitments as late as possible to save money and also to meet product demand, which causes project schedules to be increasingly compressed. One of the ways to address compressed schedules is via modularization. Modularization allows you to parallel path many of your activities, such as process-piping and equipment construction, and in parallel with some of the activities that take place to erect the building shell.

Finally, there are quality issues. Some places that you may want to build may not have quality labor resources available, or the weather or site conditions may be prohibitive. Moving the construction offsite allows you to do your construction in a better-controlled environment with higher-skilled labor.

PharmTech: What is involved in standardization of modular unit operations?

Almhem (Modular Partners): A module, in itself, is intended to be standardized. A module has a defined function with defined inputs and outputs. Once you identify a part of the process as a clear function with a clear input and output, you can design and build that as one unit. You can combine these units in different ways to create a variety of systems from a limited number of building blocks, which are the module units or unit operations. One example is a mixing skid, with the mixing system and controls all in one module.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here